Two Common Functional Polymorphisms in the Promoter Region of the Coagulation Factor VII Gene Determining Plasma Factor VII Activity and Mass Concentration
Open Access
- 15 May 1999
- journal article
- Published by American Society of Hematology in Blood
- Vol. 93 (10) , 3432-3441
- https://doi.org/10.1182/blood.v93.10.3432.410k16_3432_3441
Abstract
Recent studies have provided evidence for associations between common polymorphic markers in the coagulation factor VII (FVII) gene and plasma FVII levels. Here we describe two common, nonrelated, functional polymorphisms in the promoter region of the FVII gene, a G to T substitution at position −401 and a novel G to A substitution at position −402. Both polymorphisms strongly influence the binding properties of nuclear protein(s). The rare −401T allele is associated with a reduced basal rate of transcription of the FVII gene in human hepatoblastoma cells and with reduced plasma concentrations of total FVII (VIIag) and fully activated FVII molecules (VIIa). In contrast, the rare −402A allele confers increased transcriptional activity and is associated with increased plasma FVII levels. Together, the two polymorphisms explained 18% and 28% of the variation in VIIag and VIIa, respectively, in a group of 183 healthy, middle-aged men. It is concluded that these polymorphisms are important for the regulation of the plasma levels of FVII and that they are likely to be useful genetic markers to resolve the issue of whether a causal relationship exists between FVII levels and risk of coronary heart disease.Keywords
This publication has 42 references indexed in Scilit:
- Hemostatic Factors as Predictors of Ischemic Heart Disease and Stroke in the Edinburgh Artery StudyArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Coagulation Factor VII and the Risk of Coronary Heart Disease in Healthy MenArteriosclerosis, Thrombosis, and Vascular Biology, 1997
- Coagulation Factor VII Mass and Activity in Young Men With Myocardial Infarction at a Young AgeArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart StudyThe Lancet, 1993
- Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectorisThe American Journal of Medicine, 1992
- Elevation of factor VII activity and mass in coronary artery disease of varying severityClinical Cardiology, 1991
- Fibrinogen, factor VII clotting activity and coronary artery disease severityAtherosclerosis, 1990
- Elevation of factor VII activity and mass in young adults at risk of ischemic heart diseaseJournal of the American College of Cardiology, 1989
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- HÆMOSTATIC FUNCTION AND CARDIOVASCULAR DEATH: EARLY RESULTS OF A PROSPECTIVE STUDYThe Lancet, 1980